Loading company…
U-Needle develops and manufactures microneedle devices for intradermal and suprachoroidal injections.
Founded in 2008 and based in Enschede, Netherlands, U-Needle develops microneedle devices designed for superficial injections. It manufactures them using high-volume semiconductor processes compliant with Good Manufacturing Practices. Its Bella-mu device is used in the development of cancer vaccines using components such as neoantigens, tumor cells, mRNA, DNA and peptides. In September 2020, the company raised EUR 4.9 million in growth funding led by Holland Capital, with Waterman Ventures participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in